Post-sleeve gastrectomy weight loss: Role of botulinum toxin and semaglutide injections
Endoscopy International Open · 23.02.2026 · 14 (CP)
DOI: 10.1055/a-2793-9945 ↗Kurz gefasst
Fachartikel in der Zeitschrift Endoscopy International Open, erschienen am 23.02.2026. Verfasst von Zhengqi Li und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of General Surgery & Obesity and Metabolic Disease Center, China-Japan Friendship Hospital, Beijing, China. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 33 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Beijing Demonstration Program of Research Ward, Elite Medical Professionals Project of China-Japan Friendship Hospital, Natural Science Foundation of Beijing Municipality.
Abstract (Originalsprache)
Comparison of the therapeutic effects of endoscopic botulinum toxin (BTX) injection and semaglutide (SME) injection in treatment of patients with obesity and weight regain after laparoscopic sleeve gastrectomy (LSG). The injection method for botulinum toxin is to dilute 300 U of type A botulinum toxin with 20 mL of physiological saline. Injections were made in a grid pattern throughout the antrum and body (20 injection points total), with 1 mL of drug injected at every point. The application method for semaglutide injection is to start at 0.25 mg once a week and increase by 0.25 mg every 3 weeks until the patient can tolerate the maximum dose (1.0 mg qw), for a total of 6 months. The weight loss effect of the SME group was significantly better than that of the LSG+SME group because the SME group achieved significantly greater weight loss at 2 months than the LSG+SME group. No significant difference was seen between any other pair of groups. Endoscopic botulinum toxin injection can be a safe and effective treatment for weight regain after LSG.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of General Surgery & Obesity and Metabolic Disease Center, China-Japan Friendship Hospital, Beijing, China.
- The Third Clinical School of Medicine, Capital Medical University, Beijing, China.
- Department of Oncology, Sinopharm Tongmei General Hospital, Beijing, China.
Förderung
- Beijing Demonstration Program of Research Ward
- Elite Medical Professionals Project of China-Japan Friendship Hospital
- Natural Science Foundation of Beijing Municipality
- Key Programme
- "Kunlun Talents · High-end Innovation and Entrepreneurial Talents" project of Qinghai Province
- China-Japan Friendship Hospital Talent Introduction Project
- National High Level Hospital Clinical Research Funding
Zitieren
APA
Li, Z., Zhang, S., Nie, Y., Wang, P., Liu, B., Zhou, B., Zhang, N., Wang, S., Chou, S., Zhang, L., Wang, Z., & Meng, H. (2026). Post-sleeve gastrectomy weight loss: Role of botulinum toxin and semaglutide injections. Endoscopy International Open, 14(CP). https://doi.org/10.1055/a-2793-9945
Vancouver
Li Z, Zhang S, Nie Y, Wang P, Liu B, Zhou B, et al. Post-sleeve gastrectomy weight loss: Role of botulinum toxin and semaglutide injections. Endoscopy International Open. 2026;14(CP). doi:10.1055/a-2793-9945
BibTeX
@article{Li2026,
author = {Li, Zhengqi and Zhang, Shaohan and Nie, Yuntao and Wang, Pengpeng and Liu, Baoyin and Zhou, Biao and Zhang, Nianrong and Wang, Siqi and Chou, Sai and Zhang, Lei and Wang, Zhe and Meng, Hua},
title = {Post-sleeve gastrectomy weight loss: Role of botulinum toxin and semaglutide injections},
journal = {Endoscopy International Open},
year = {2026},
volume = {14},
number = {CP},
doi = {10.1055/a-2793-9945}
}
EUVIMED